BREAKING
CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline 42 minutes ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 13 hours ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 13 hours ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 16 hours ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 18 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 20 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 22 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 24 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 1 day ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 1 day ago CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline 42 minutes ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 13 hours ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 13 hours ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 16 hours ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 18 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 20 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 22 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 24 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 1 day ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 1 day ago
ADVERTISEMENT
AlphaGraphs

PFE Earnings: Key quarterly highlights from Pfizer’s Q3 2024 financial results

Pfizer Inc. (NYSE: PFE) reported its third quarter 2024 earnings results today. Revenues increased 31% year-over-year to $17.7 billion. Revenues increased 32% operationally. Net income was $4.46 billion, or $0.78 per share, compared to a loss of $2.38 billion, or $0.42 per share, last year. Adjusted EPS amounted to $1.06. Revenue and earnings beat expectations. […]

October 29, 2024 1 min read

Pfizer Inc. (NYSE: PFE) reported its third quarter 2024 earnings results today.

Revenues increased 31% year-over-year to $17.7 billion. Revenues increased 32% operationally.

Net income was $4.46 billion, or $0.78 per share, compared to a loss of $2.38 billion, or $0.42 per share, last year. Adjusted EPS amounted to $1.06.

Revenue and earnings beat expectations.  

For the full year of 2024, Pfizer expects revenues of $61-64 billion and adjusted EPS of $2.75-2.95.

ADVERTISEMENT

The stock gained over 1% in premarket hours on Tuesday.

Prior performance

ADVERTISEMENT